• SENSEX 76,617.44
    592.93 (+0.78%)
  • BANKNIFTY 51,348.05
    520.55 (+1.02%)
  • IndusInd Bank
    708.45 1,576.00(%)
  • Kalyan Jewellers
    519.15 794.60(%)
  • Dr Lal Pathlabs
    2,508.00 3,645.00(%)
  • ICICI BLR Growth
    1,003.14 1,001.47(%)
  • Vodafone Idea
    8.33 19.15(%)
  • Bharat Electron
    274.50 204.00(%)
  • Quadrant Future
    605.00 743.45(%)
  • Zomato Ltd
    212.60 304.50(%)
  • SRF
    2,986.25 3,074.95(%)
  • Bengal & Assam
    7,450.00 11,498.90(%)
  • ICICI Bank
    1,338.00 1,372.50(%)
  • Mazagon Dock
    2,610.00 2,929.98(%)
  • Suzlon Energy
    57.74 86.04(%)
  • SpiceJet
    46.10 79.90(%)
  • Dixon Technolog.
    13,485.00 19,149.80(%)
  • Adani Green
    944.95 2,173.65(%)
  • Aegis Logistics
    830.35 1,035.70(%)
  • Hind.Aeronautics
    4,252.00 5,675.00(%)
  • M & M
    2,660.50 3,276.30(%)
  • Nippon ETF Liq.
    999.99 996.00(%)
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison
Overview
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison

Ajanta Pharma Ltd Pharmaceuticals - Indian - Formulations

  • Indian Private
  • BSE Code : 13504.0
  • ISIN : INE031B01049
2,617.75 0 (0.01%)
  • As on 03 Apr 2025 (EOD)

  • Today’s Low

    2,581.30

  • Today’s High

    2,649.70

  • Open

    2,617.40

  • Perv Close

    2,617.40

  • 52W Low

    2,051.60

  • 52W High

    3,485.00

Key Indicators

  • P/E(TTM)

    36.91

  • Mar.Cap (₹Cr.)

    32,698.86

  • Div & Yield %

    1.97

  • Book Value(₹)

    282.56

  • Debt-Equity Ratio

    0.01

  • AGM Date

    02-Apr-2025

  • EPS

    70.94

  • P/E Ratio

    36.91

Financials Ratios

  • Debt-Equity Ratio

    0.01

  • Mar.Cap (₹Cr.)

    32,698.86

  • RONW (%)

    23.47

  • ROCE (%)

    31.59

Score Board

  • Equity (₹ in Cr.)

    24.98

  • BV (₹)

    282.60

  • Sales( ₹ in Cr.)

    3,971.12

  • NP (in Cr.)

    796.13

  • NP Var(%)

    46.0

  • Div%

    2550.0

  • CPS (₹)

    74.30

  • EPS (₹)

    63.70

  • Traded Value (₹ in Lakhs)

    32,703.24

  • 52 Week High

    3,485.00

  • 52 Week Low

    2,051.60

  • Price BSE

    2618.0

  • Price NSE

    2,618.00

  • Market Capital( in Cr.)

    32,703.24

  • P/C Ratio

    35.20

  • P/E Ratio

    41.10

  • Price Vs.BV

    63.70

View More
Invest Now!

Navigate The Market With Confidence

Your all-in-one destination for expert investment guidance and streamlined portfolio management solutions

Financials

All Values are in (₹Cr)
Particulars(INCOME) Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Mar 2019
Sales Turnover 3,971.12 3,411.27 3,140.64 2,718.59 2,196.42 1,772.62
Excise Duty 3,924.00 3,376.15 3,083.78 2,674.10 2,167.07 1,731.36
Net Sales 3,971.12 3,411.27 3,140.64 2,718.59 2,196.42 1,772.62
Other Income 116.48 132.75 139.73 103.57 184.20 102.15
Stock Adjustments 0.00 0.00 0.00 0.00 0.00 0.00
Total Income 4,087.60 3,544.02 3,280.37 2,822.16 2,380.62 1,874.77
EXPENDITURE :
Raw Materials 3,924.00 3,376.15 3,083.78 2,674.10 2,167.07 1,731.36
Power & Fuel Cost 3,924.00 3,376.15 3,083.78 2,674.10 2,167.07 1,731.36
Employee Cost 834.16 720.41 585.87 498.11 437.82 389.37
Other Manufacturing Expenses 115.68 132.19 94.82 86.51 89.89 89.67
Selling & Administrative Expenses 599.82 615.48 522.69 332.62 315.39 270.33
Miscellaneous Expenses 115.68 132.19 94.82 86.51 89.89 89.67
Less : Pre-operative Expenses Capitalised :
Total Expenditure 2,990.65 2,844.17 2,379.83 1,920.07 1,764.03 1,361.72
Operating Profit 222.61 238.50 213.81 154.36 156.57 149.92
Interest 6.80 5.23 9.12 6.90 9.10 0.41
Gross Profit 1,096.95 699.85 900.54 902.09 612.67 513.05
Depreciation 132.16 126.95 120.96 111.49 91.29 69.90
Profit Before Tax 1,096.95 699.85 900.54 902.09 612.67 513.05
Tax 253.74 122.40 196.72 225.06 168.09 108.66
Fringe Benefit tax 0.00 0.00 0.00 0.00 0.00 0.00
Deferred Tax 9.15 0.05 9.51 9.77 3.45 12.63
Reported Net Profit 807.24 558.72 719.86 675.64 441.13 391.76
Extraordinary Items 1,096.95 699.85 900.54 902.09 612.67 513.05
Adjusted Net Profit 807.24 558.72 719.86 675.64 441.13 391.76
Adjustment below Net Profit 0.00 0.00 0.00 0.00 0.00 0.00
P & L Balance brought forward 0.00 0.00 0.00 0.00 0.00 0.00
Statutory Appropriations 642.17 89.69 82.21 82.90 113.44 79.22
P & L Balance carried down 807.24 558.72 719.86 675.64 441.13 391.76
Dividend - - - - - -
Preference Dividend - - - - - -
Equity Dividend (%) 2,550.00 350.00 475.00 475.00 650.00 450.00
Dividend Per Share(Rs) 51.00 7.00 9.50 9.50 13.00 9.00
Earnings Per Share-Unit Curr 64.11 43.61 55.52 77.59 50.55 44.52
Book Value 642.17 89.69 82.21 82.90 113.44 79.22
Book Value(Adj)-Unit Curr 642.17 89.69 82.21 82.90 113.44 79.22

Shareholding Pattern

  • Promoter Group

    66.26%

  • Public Share Holding

    33.74%

Category of Shareholder No of Shares % Holdings Demat Shares Shareholders
A]. Promoter & Group
Foreign (Promoter & Group) - Bodies Corporate 0 0.00 0 0
Foreign (Promoter & Group)-Individuals (Non-Resident / Foreign) 0 0.00 0 0
Foreign Promoter(Institutional) 0 0.00 0 0
Promoter Others 0 0.00 0 0
Sub Total 0 0.00 0 0
[2] INDIAN
Bodies Corporate-Indian (Promoter & Group) 12,588,393 10.08 12,588,393 1
Government(Central / State)-Indian (Promoter & Group) 0 0.00 0 0
Directors & their Relatives-Indian (Promoter & Group) 0 0.00 0 0
Financial Institutions / Banks-Indian (Promoter & Group) 0 0.00 0 0
Individuals / Hindu Undivided Family-Indian (Promoter & Group) 70,175,384 56.18 70,175,384 7
Partnership Firms-Indian (Promoter & Group) 0 0.00 0 0
Persons Acting in Concert 0 0.00 0 0
Trusts 0 0.00 0 0
Others 0 0.00 0 0
Sub Total 82,763,777 66.26 82,763,777 8
Total ShareHolding for Promoter & Group
B]. Publice Share Holding
1] Institution
Government(Central / State) 10,872 0.01 10,872 1
Clearing Members 0 0.00 0 0
Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
Financial Institutions / Banks 55 0.00 55 1
Foreign Bank 0 0.00 0 0
Foreign Bodies Corporate/OCBs/FBC 0 0.00 0 0
Foreign Collaborators 0 0.00 0 0
Foreign Institutional Investors 11,564,987 9.26 11,564,987 306
Foreign Venture Capital Investors 0 0.00 0 0
Foreign Institution Other 0 0.00 0 0
Insurance Companies 1,849,971 1.48 1,849,971 12
Mutual Funds / UTI 18,601,737 14.89 18,601,737 28
Individuals (Non-Resident / Foreign) 0 0.00 0 0
NSDL Intransit 0 0.00 0 0
Others 810,819 0.65 810,819 25
Trusts 0 0.00 0 0
Venture Capital Funds 0 0.00 0 0
Sub total 32,838,441 26.29 32,838,441 373
2] Non Institution
Bodies Corporate 234,138 0.19 233,013 581
Clearing Members 1,171 0.00 1,171 8
Directors of their Relatives 0 0.00 0 0
Employees 0 0.00 0 0
Escrow Account 0 0.00 0 0
Foreign Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
NRIs/Foreign Individuals/Foreign Nationals 403,460 0.32 401,773 2,772
Foreign Non Institution Other 0 0.00 0 0
Hindu Undivided Families 177,389 0.14 177,389 1,201
Indian Public 0 0.00 0 0
Individuals holding nominal share capital in excess of Rs. 1 lakh 852,988 0.68 852,988 5
Individuals holding nominal share capital up to Rs. 1 lakh 7,475,026 5.98 7,298,702 61,877
Market Maker 0 0.00 0 0
NSDL Transit 0 0.00 0 0
Shares in transit 0 0.00 0 0
Societies 0 0.00 0 0
Trust & Foundation 3,793 0.00 3,793 6
Others 135,071 0.11 135,071 3
Sub Total 9,309,881 7.45 9,130,745 66,515
Total Public Shareholding
C]. Shares held by Custodians and against which Depository Receipts have been issued
ADR 0 0.00 0 0
GDR 0 0.00 0 0
Other Custodians 0 0.00 0 0
Total Shares held by Custodians and against which Depository Receipts have been issued 0 0.00 0 0
Grand Total ( A + B + C ) 124,912,099 100.00 124,732,963 66,896

Company Background

Ajanta Pharma LtdPharmaceuticals - Indian - Formulations

  • Ajanta Pharma Ltd
  • BSE Code : 13504.0
  • ISIN : INE031B01049

  • Incorporation Year

    1979

  • Registered Office

    Ajanta House
    Charkop Kandivli (W), Mumbai,
    Maharashtra-400067

  • Telephone

    91-22-66061000/1204/1203

  • FAX

    91-22-66061200/1300

  • Chairman

    Mannalal B Agrawal

  • Managing Director

    Yogesh Agrawal

  • Company Secretary

    Gaurang Shah

  • Auditor

    B S R & Co LLP

  • Face Value

    2

  • Listing

    NSE

  • Registrar

    MUFG Intime India Pvt Ltd
    C-101 247 Park,
    L B S Marg,Vikhroli West
    Mumbai - Mumbai-400083

Ajanta Pharma Ltd Peer Comparison

Profit & Loss
Financial Ratios
Balance Sheet
Select Company Name LTP (₹) Revenue Sales P/E Ratio ROCE %
Ajanta Pharma 2,618.10 4,087.60 3,971.12 36.91 32.49
Abbott India 29,572.60 6,097.18 5,848.91 47.09 44.71
Astrazeneca Phar 8,100.10 1,330.33 1,295.53 208.82 33.26
P & G Health Ltd 5,259.35 1,166.89 1,151.26 36.90 39.76
Glaxosmi. Pharma 2,776.60 3,530.73 3,407.25 55.21 44.44
Cipla 1,452.70 17,645.00 16,574.34 24.90 20.10
Amrutanjan Healt 645.10 437.58 421.23 37.81 20.84
Fermenta Biotec. 292.05 315.24 307.09 27.68 4.10
Guj. Themis Bio. 272.20 174.19 169.82 56.36 44.82
Bliss GVS Pharma 120.00 638.96 605.46 27.46 11.19
Ambalal Sarabhai 37.31 11.70 3.81 15.94 1.92